/
RxSight, Inc. is a commercial-stage medical technology company dedicated to providing high-quality customized vision to patients following cataract surgery. Our proprietary RxSight Light Adjustable Lens system ( RxSight system ) is the first and only commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery.
The business is unprofitable at the operating level (-35.84% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 3.9% YoY. Margins deteriorated 9.5pp alongside, both lines moving the wrong way.
Negative free cash flow of -$19M. The business is consuming cash, not generating it. Operating margin contracted 9.5pp YoY, cost discipline may be slipping.
Profitability & Returns
Revenue (TTM)
$127M
▼ -3.9% YoY
Net Income (TTM)
-$47M
▼ -41.8% YoY
Op. Margin
-43.42%
▼ -9.5pp YoY
ROIC
-15.31%
▼ -0.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$22M
▲ +13.6% YoY
Op. Cash Flow (TTM)
-$18M
▲ +8.5% YoY
Net Debt
-$207M
Net Cash Position
Cash & Equiv.
$218M
5Y CAGR: +55.7%
Continue Research